Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;99(3):306-314.
doi: 10.1111/cen.14921. Epub 2023 Jun 11.

Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)-secreting pituitary adenomas

Jie Liu  1 , Yamei Yang  2   3 , Lian Duan  2   3 , Xiaofeng Chai  2   3 , Huijuan Zhu  2   3 , Kan Deng  1 , Xiaolan Lian  2   3 , Yong Yao  1
Affiliations

Characteristics and response cutoff of octreotide suppression test in thyrotrophin (TSH)-secreting pituitary adenomas

Jie Liu et al. Clin Endocrinol (Oxf). 2023 Sep.

Abstract

Context: Somatostatin analogs are recommended for preoperative therapy in thyrotrophin secreting pituitary adenomas (TSHomas). Octreotide suppression test (OST) was designed to differentiate TSHomas with resistance to thyroid hormones, while its ability to test the sensitivity of SSA has not been fully studied.

Objective: To test the sensitivity of SSA in TSHomas with OST.

Patients: We collected 48 pathologically confirmed TSHoma patients with complete 72 h' data of OST into analysis.

Intervention: Octreotide suppression test.

Main outcome: Sensitivity timepoint and cutoff of OST.

Results: During the entire OST, the TSH descended maximally 89.07% (73.85%, 96.77%), while the FT3 and FT4 declined slowly [43.40% (37.80%, 54.44%) and 26.59% (19.01%, 33.13%), respectively]. The 24th hour was the timepoint wherein the stability occurs for TSH, and the 48th hour for FT3 and FT4 during OST. In the patients who received both short- and long-acting somatostatin analogs (SSA), the 24-h timepoint was the most predictive timepoint for the percentage of TSH decline (Spearman's rank correlation analysis, r = .571, p < .001), while the 72-h timepoint was optimal for predicting the magnitude of TSH decline (Spearman's rank correlation analysis, r = .438, p = .005). In the 24th timepoint, a positive correlation was also observed between TSH suppression rate and the percentage decrease and absolute value decrease of FT3 and FT4. Furthermore, in patients treated with long-acting SSA, the 72-h timepoint was optimal for predicting both the percentage (Spearman's rank correlation analysis, r = .587, p = .01) and magnitude (Spearman's rank correlation analysis, r = .474, p = .047) of TSH decline. The 24th hour was the optimal timepoint with 44.54% (50% of median value of TSH in 72-hOST) decrease of TSH being the observing cutoff. The adverse effect of OST was predominantly occurred in the gastrointestinal system and no severe event occurred during OST. Paradoxical response could occur in OST and it did not influence the effect of SSA as long as sensitivity was confirmed. A high level of hormonal control was achieved in the SSA-sensitive patients.

Conclusion: OST can be used as an efficient tool to guide the adequate use of SSA.

Keywords: octreotide suppression test; response cutoff; somatostatin analogs; thyroid function tests; thyrotrophin (TSH)-secreting pituitary adenomas; transsphenoidal surgery; treatment outcome.

PubMed Disclaimer

References

REFERENCES

    1. Molitch ME. Diagnosis and treatment of pituitary adenomas. JAMA. 2017;317(5):516. doi:10.1001/jama.2016.19699
    1. Melmed S. Pituitary-Tumor endocrinopathies. N Engl J Med. 2020;382(10):937-950. doi:10.1056/NEJMra1810772
    1. Jailer JW, Holub DA. Remission of Graves’ disease following radiotherapy of a pituitary neoplasm. Am J Med. 1960;28:497-500. doi:10.1016/0002-9343(60)90181-9
    1. Önnestam L, Berinder K, Burman P, et al. National incidence and prevalence of TSH-secreting pituitary adenomas in Sweden. J Clin Endocrinol Metabo. 2013;98(2):626-635. doi:10.1210/jc.2012-3362
    1. De Herdt C, Philipse E, De Block C. Endocrine tumours: thyrotropin-secreting pituitary adenoma: a structured review of 535 adult cases. Eur J Endocrinol. 2021;185(2):R65-R74. doi:10.1530/EJE-21-0162

Publication types

LinkOut - more resources